BEDFORD, Mass., Sept. 20, 2019 /PRNewswire/ -- Access Vascular, Inc. has been awarded a group purchasing agreement for a Breakthrough Technology contract with Premier. Effective September 1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the HydroPIC

NEWPORT BEACH, Calif. and BERLIN, Sept. 20, 2019 /PRNewswire/ -- Today, GABA Therapeutics, a biotech company focused on the treatment of mood disorders, and

NASHVILLE, Tenn., Sept. 20, 2019 /PRNewswire/ -- Qualifacts, one of the largest Software-as-a-Service (SaaS) electronic health record providers (EHR) for behavioral health and human service organizations, today announced that Warburg Pincus, a leading global private equity firm focused on growth investing, has acquired the company from the previous investor, Great H

MIAMI, Sept. 20, 2019 /PRNewswire/ -- As part of a commitment to building healthier communities, CVS Health (NYSE: CVS) celebrated the expansion of its annual

ATLANTA, Sept. 20, 2019 /PRNewswire/ -- As part of a commitment to building healthier communities, CVS Health (NYSE: CVS) celebrated the expansion of its annual

FRANKFURT, Germany and BUDAPEST, Hungary, Sept. 20, 2019 /PRNewswire/ -- Innoplexus announces an official partnership with ChemAxon, getting the most value out from life sciences data. T

DALLAS, Sept. 20, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, a

EMERYVILLE, Calif., Sept. 20, 2019 /PRNewswire/ -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the B. Riley FBR Annual Consumer & Media Conference to be held

MANHASSET, N.Y., Sept. 20, 2019 /PRNewswire/ -- Feinstein Institutes for Medical Research scientists have been awarded a five-year,

SAN FRANCISCO, Sept. 20, 2019 /PRNewswire/ -- InsightRX, a pioneer in precision medicine, announced today the closing of its $10 million Series A funding led by HealthX Vent